Vaccines and profit – a test case for stewardship

November 16, 2020

So… on the day their partners BioNTec announced the success of their vaccine trial, Albert Bourla, the CEO of Pfizer

Why ESG isn’t enough

November 10, 2020

The ESG label is now used so frequently that it is in danger of becoming a substitute for thought.

What …